Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke

Background and Purpose: Fever after stroke is a strong predictor for a negative outcome with infections as the most common cause. The aim of this pilot study was to evaluate the effects of prophylactic antibiotic therapy on the incidence and height of fever after acute ischemic stroke. Methods: This...

Full description

Saved in:
Bibliographic Details
Main Authors: Schwarz, Stefan (Author) , Al-Shajlawi, Frank (Author) , Sick, Christian (Author) , Meairs, Stephen (Author) , Hennerici, Michael G. (Author)
Format: Article (Journal)
Language:English
Published: [1 April 2008]
In: Stroke
Year: 2008, Volume: 39, Issue: 4, Pages: 1220-1227
ISSN:1524-4628
DOI:10.1161/STROKEAHA.107.499533
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/STROKEAHA.107.499533
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/STROKEAHA.107.499533
Get full text
Author Notes:Stefan Schwarz, MD, Frank Al-Shajlawi, MD, Christian Sick, MD, Stephen Meairs, MD, and Michael G. Hennerici, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1752585399
003 DE-627
005 20230427070822.0
007 cr uuu---uuuuu
008 210326s2008 xx |||||o 00| ||eng c
024 7 |a 10.1161/STROKEAHA.107.499533  |2 doi 
035 |a (DE-627)1752585399 
035 |a (DE-599)KXP1752585399 
035 |a (OCoLC)1341401355 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schwarz, Stefan  |d 1966-  |e VerfasserIn  |0 (DE-588)172656737  |0 (DE-627)697590356  |0 (DE-576)133515362  |4 aut 
245 1 0 |a Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke  |c Stefan Schwarz, MD, Frank Al-Shajlawi, MD, Christian Sick, MD, Stephen Meairs, MD, and Michael G. Hennerici, MD 
264 1 |c [1 April 2008] 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.03.2021 
520 |a Background and Purpose: Fever after stroke is a strong predictor for a negative outcome with infections as the most common cause. The aim of this pilot study was to evaluate the effects of prophylactic antibiotic therapy on the incidence and height of fever after acute ischemic stroke. Methods: This is a randomized, controlled study of antibiotic prophylaxis in patients with ischemic stroke enrolled within 24 hours from clinical onset who presented bedridden (modified Rankin score >3) with no significant infection. Interventions included prophylactic mezlocillin plus sulbactam (3×2 g/1 g for 4 days) or conventional management. Over 10 days, body temperature was continuously monitored, and the presence of infection was daily assessed. Primary end points were incidence and height of fever; secondary end points included rate of infection and clinical outcome. Results: Sixty patients were included (mean, 75 years; median National Institutes of Health Stroke Scale score, 16). Over the first 3 days, patients in the intervention group showed lower mean body temperatures as well as lower daily peak temperatures (P<0.05). Throughout the observation period, 15 of 30 patients in the intervention group but 27 of 30 patients in the conventionally treated group developed an infection (P<0.05). Mean interval until the diagnosis of infection was 5.1 days in the intervention group and 3.3 days in the control group (P<0.05). Clinical outcome was more favorable in patients with prophylactic therapy (P=0.01).Conclusions: In patients with acute severe stroke, prophylactic administration of mezlocillin plus sulbactam over 4 days decreases body temperature, lowers the rate of infection, and may be associated with a better clinical outcome. 
700 1 |a Al-Shajlawi, Frank  |d 1966-  |e VerfasserIn  |0 (DE-588)120790491  |0 (DE-627)704990261  |0 (DE-576)29238680X  |4 aut 
700 1 |a Sick, Christian  |d 1974-  |e VerfasserIn  |0 (DE-588)1044448008  |0 (DE-627)77205584X  |0 (DE-576)397665059  |4 aut 
700 1 |a Meairs, Stephen  |d 1951-  |e VerfasserIn  |0 (DE-588)102747103X  |0 (DE-627)729172929  |0 (DE-576)373246048  |4 aut 
700 1 |a Hennerici, Michael G.  |d 1948-  |e VerfasserIn  |0 (DE-588)11587545X  |0 (DE-627)077527704  |0 (DE-576)290126444  |4 aut 
773 0 8 |i Enthalten in  |t Stroke  |d New York, NY : Association, 1970  |g 39(2008), 4, Seite 1220-1227  |h Online-Ressource  |w (DE-627)266879985  |w (DE-600)1467823-8  |w (DE-576)075145731  |x 1524-4628  |7 nnas  |a Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke 
773 1 8 |g volume:39  |g year:2008  |g number:4  |g pages:1220-1227  |g extent:8  |a Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke 
856 4 0 |u https://doi.org/10.1161/STROKEAHA.107.499533  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/STROKEAHA.107.499533  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210326 
993 |a Article 
994 |a 2008 
998 |g 11587545X  |a Hennerici, Michael G.  |m 11587545X:Hennerici, Michael G.  |d 60000  |d 62700  |e 60000PH11587545X  |e 62700PH11587545X  |k 0/60000/  |k 1/60000/62700/  |p 5  |y j 
998 |g 102747103X  |a Meairs, Stephen  |m 102747103X:Meairs, Stephen  |d 60000  |d 62700  |e 60000PM102747103X  |e 62700PM102747103X  |k 0/60000/  |k 1/60000/62700/  |p 4 
998 |g 1044448008  |a Sick, Christian  |m 1044448008:Sick, Christian  |d 60000  |d 62700  |e 60000PS1044448008  |e 62700PS1044448008  |k 0/60000/  |k 1/60000/62700/  |p 3 
998 |g 120790491  |a Al-Shajlawi, Frank  |m 120790491:Al-Shajlawi, Frank  |d 60000  |d 61100  |e 60000PA120790491  |e 61100PA120790491  |k 0/60000/  |k 1/60000/61100/  |p 2 
998 |g 172656737  |a Schwarz, Stefan  |m 172656737:Schwarz, Stefan  |d 60000  |e 60000PS172656737  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1752585399  |e 3894830980 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Stefan Schwarz, MD, Frank Al-Shajlawi, MD, Christian Sick, MD, Stephen Meairs, MD, and Michael G. Hennerici, MD"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"id":{"issn":["1524-4628"],"zdb":["1467823-8"],"eki":["266879985"]},"recId":"266879985","title":[{"title_sort":"Stroke","title":"Stroke","subtitle":"journal of the American Heart Association"}],"note":["Gesehen am 29.06.04"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic strokeStroke","pubHistory":["1.1970 -"],"origin":[{"dateIssuedDisp":"1970-","publisher":"Association ; Lippincott Williams & Wilkins","dateIssuedKey":"1970","publisherPlace":"New York, NY ; Philadelphia, Pa."}],"corporate":[{"role":"isb","display":"American Heart Association","roleDisplay":"Herausgebendes Organ"}],"part":{"pages":"1220-1227","volume":"39","issue":"4","extent":"8","text":"39(2008), 4, Seite 1220-1227","year":"2008"}}],"origin":[{"dateIssuedDisp":"[1 April 2008]","dateIssuedKey":"2008"}],"note":["Gesehen am 26.03.2021"],"person":[{"family":"Schwarz","display":"Schwarz, Stefan","roleDisplay":"VerfasserIn","given":"Stefan","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Al-Shajlawi","display":"Al-Shajlawi, Frank","role":"aut","given":"Frank"},{"display":"Sick, Christian","family":"Sick","roleDisplay":"VerfasserIn","given":"Christian","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Meairs, Stephen","family":"Meairs","given":"Stephen","role":"aut"},{"role":"aut","given":"Michael G.","roleDisplay":"VerfasserIn","display":"Hennerici, Michael G.","family":"Hennerici"}],"title":[{"title":"Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke","title_sort":"Effects of prophylactic antibiotic therapy with Mezlocillin Plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1752585399"],"doi":["10.1161/STROKEAHA.107.499533"]},"language":["eng"],"physDesc":[{"extent":"8 S."}],"recId":"1752585399"} 
SRT |a SCHWARZSTEEFFECTSOFP1200